Analytical tool hematological cancers offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in r&d and business development in hematological cancers.
City, State, Country., April 18, 2014 - (PressReleasePoint) -Analytical Tool - Hematological Cancers | Market Research Report
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides an immense amount of information structured and analyzed to assist you in work. It is designed to assist in finding right partners, optimizing the licensing deals, wisely choosing which projects gives the best competitive advantage, and assuring that decisions have been based on the most accurate, validated and precise facts available.
Included in this advantageous package are three products already appreciated by many of the customers:
A Decision Support Tool for Optimizing The Leukemia Pipeline: From Research and Development to Market
A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
Hematological Cancers Drug Pipeline Update 2013*
The Package Includes:
- A progress analysis on current and emerging drugs
- Information on most companies active in R&D
- Information on key industry related projects
- Data from most important clinical trials
- Information on early developmental stage projects
- Possibility of performing advanced searches suited to the individual needs
This Tool will Assist in:
- Tracking cutting edge companies, therapies and new technologies
- Rapid identification of partners & competitors
- Laying down a comprehensive framework for further analysis of the field
- Producing presentations surrounding the development of hematological cancer therapeutics
- Identifying emerging products & key areas of pharmaceutical R&D
This software application is a searchable database reflects the most recent advances in the field of hematological cancer drug development, in order to perform the own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeekers software applications give better overview, specific search capabilities and great dynamic reports.
Press Contact: Sachin Podar Center, 85 Parel Post Office Lane, Off Dr. Ambedkar Road, Parel East, +91 22 4098 7600 ******.******@n**s**i**s.com Email partially hidden to block spam. Please use the contact form here.